Financial Data and Key Metrics Changes - Total investment income for Q3 2025 was $36.7 million, up from $35.1 million in Q2 2025, while net investment income increased to $15.7 million from $13.9 million [15][16] - The weighted average portfolio risk rating rose to 2.42 in Q3 2025 from 2.33 in Q2 2025 [15] - The dollar-weighted loan-to-value ratio increased from 29.6% to 31.4% [15] - The total investment portfolio's fair value decreased by 7.7% to $946 million from $1.02 billion [16] - NAV per share decreased by 1.9% to $13.55 from $13.66 [18] Business Line Data and Key Metrics Changes - The company completed 11 investments totaling $128.3 million in Q3 2025, focusing on technology, healthcare, and select consumer sectors [7][10] - The acquisition of SWK Holdings is expected to scale the portfolio by approximately $242 million, increasing exposure in healthcare and life sciences from 14% to 31% [9][11] Market Data and Key Metrics Changes - The company noted a competitive environment in private markets, with increased competition affecting pricing and origination activity [9][34] - The venture debt space is experiencing spread compression, although not as severe as in broader markets [34] Company Strategy and Development Direction - The company aims to enhance its portfolio through both organic and inorganic growth, with a focus on diversification and risk mitigation [8][9] - The acquisition of SWK Holdings is seen as a strategic move to enhance earnings power and diversify the asset base [9][20] - The company is committed to maintaining a disciplined approach to growth while leveraging the BC Partners credit platform for sourcing opportunities [8][10] Management's Comments on Operating Environment and Future Outlook - Management expects a muted repayment activity in Q4 2025 compared to Q3, with origination opportunities being actively pursued [25] - The integration of SWK is anticipated to enhance the company's financial profile and shareholder value, with expected accretion in earnings [20][55] - The ongoing government shutdown may delay SEC regulatory approval for the merger, with a projected close in early 2026 [22][55] Other Important Information - The company repurchased 397,983 shares during the third quarter under a $25 million stock repurchase program [22] - A regular distribution of $0.33 per share was declared for Q4 2025 [23] Q&A Session Summary Question: Expected closing date of the SWK merger and origination activity in Q4 - Management indicated that repayments would be muted in Q4, with origination activity utilizing the existing pipeline and BC Partners credit platform [25] Question: Integration of SWK portfolio and yield profile - The SWK portfolio is expected to have a slightly higher yield than Runway's existing portfolio, with plans to explore upsizing the best loans post-merger [27][29] Question: Drivers of realized loss and unrealized portfolio depreciation - Losses were primarily in the equity portfolio, with no specific sector theme identified [30] Question: Prepayment activity and expectations for next year - Prepayment activity is driven by M&A and refinancing options, with expectations for normal prepayment rates moving forward [31] Question: Competitive dynamics in venture debt space - Management noted spread compression in the venture debt space, but not as severe as in other markets [34] Question: Integration of SWK team post-merger - The SWK team will assist with the transition and new originations during the integration period [35] Question: Dividend declaration and earnings power - The board's decision on the dividend was based on anticipated prepayment activity and the need to cover the base dividend with Q4 earnings [38][40] Question: Characteristics of loans added to the Kadma JV - Loans added to the Kadma JV are growth loans, suited for that vehicle due to specific characteristics [46] Question: Accretion from the SWK merger - The merger is expected to be accretive in the first full quarter after closing, with potential for OID accretion [55][56]

Financial Data and Key Metrics Changes - Total investment income for Q3 2025 was $36.7 million, an increase from $35.1 million in Q2 2025, while net investment income rose to $15.7 million from $13.9 million [15][16] - The weighted average portfolio risk rating increased to 2.42 from 2.33 in the previous quarter [15] - The dollar-weighted loan-to-value ratio increased from 29.6% to 31.4% [15] - The total investment portfolio's fair value decreased by 7.7% to $946 million from $1.02 billion [16] - NAV per share decreased by 1.9% to $13.55 from $13.66 [18] Business Line Data and Key Metrics Changes - The company completed 11 investments totaling $128.3 million in Q3 2025, including new investments in Federal Hearings and Appeals Services and DigiCert Inc. [10][11] - The acquisition of SWK Holdings is expected to scale the portfolio by approximately $242 million, increasing exposure in healthcare and life sciences from 14% to 31% [9][11] Market Data and Key Metrics Changes - The debt portfolio generated a dollar-weighted average annualized yield of 16.8%, up from 15.4% in the previous quarter [16] - Total available liquidity was $371.9 million, including unrestricted cash and cash equivalents [18] Company Strategy and Development Direction - The company is focused on both organic and inorganic growth, with a definitive merger agreement to acquire SWK Holdings to enhance its portfolio and earnings power [5][9] - The strategy includes diversifying the portfolio through smaller position sizes and expanding financing solutions [7][11] - The company aims to maintain a disciplined approach to growth while leveraging the BC Partners credit platform for sourcing opportunities [6][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the merger with SWK Holdings, anticipating it will enhance earnings power and financial profile [20][21] - The company expects to see a normal course of prepayments and is optimistic about origination activity in Q4 2025 [26][33] - Management acknowledged competitive dynamics in the venture debt space, noting some spread compression but not as severe as in broader markets [37] Other Important Information - The company declared a regular distribution for Q4 2025 of $0.33 per share, with net investment income of $0.43 per share [24][42] - The merger is structured as a NAB-for-NAB transaction with an estimated purchase price of approximately $220 million [21] Q&A Session Summary Question: What should be expected regarding origination and repayment activity in Q4? - Management indicated that repayments would likely be muted compared to Q3, with ongoing origination opportunities available [26] Question: What is the yield profile expected after integrating the SWK portfolio? - The SWK portfolio is expected to have a slightly higher yield than the current portfolio, with pro formas to be provided in future filings [27][28] Question: What drove the realized loss and unrealized portfolio depreciation? - Losses were primarily in the equity portfolio, attributed to idiosyncratic factors rather than sector-wide issues [31][32] Question: What is driving prepayment activity, and is it expected to continue? - Prepayment activity is driven by M&A activity and companies finding cheaper refinancing options, with expectations for normal prepayment rates moving forward [33] Question: How will the SWK team be integrated into the company? - The SWK team will assist with the transition and new originations during the integration period [38] Question: Will the merger be accretive in 2026? - Management expects the merger to be accretive in the first full quarter after closing [59] Question: What stage of development do typical SWK investments target? - SWK targets growth-stage companies that are generating revenue but are generally pre-profit [62]

Core Insights - Runway Growth Finance Corp. reported total investment income of $36.7 million and net investment income of $15.7 million for Q3 2025, maintaining similar levels compared to Q3 2024 [4][6][7] - The company declared a fourth quarter dividend of $0.33 per share, reflecting its ongoing commitment to return value to shareholders [3][13] - The investment portfolio as of September 30, 2025, had a fair value of $0.9 billion, with a focus on senior secured loans [9][11] Financial Performance - Total investment income for Q3 2025 was $36.7 million, unchanged from Q3 2024 [4] - Net investment income for Q3 2025 was $15.7 million, or $0.43 per share, compared to $15.9 million, or $0.41 per share, in Q3 2024 [6][8] - Operating expenses increased slightly to $21.0 million in Q3 2025 from $20.8 million in Q3 2024 [6] Investment Activity - The company completed 11 investments totaling $128.3 million during the third quarter, net of refinances [7][10] - The investment portfolio included $878.8 million in loans, with 97.6% being senior secured loans [9] - The company experienced a net realized loss on investments of $1.3 million in Q3 2025, compared to no realized gains or losses in Q3 2024 [7] Net Asset Value - As of September 30, 2025, the net asset value per share was $13.55, a decrease of 0.8% from $13.66 as of June 30, 2025 [11] - Total net assets at the end of Q3 2025 were $489.5 million [11] Liquidity and Capital Resources - The company had approximately $371.9 million in available liquidity, including $7.9 million in cash and $364.0 million in borrowing capacity [12] - The core leverage ratio improved to approximately 92% from 105% in the previous quarter [12] Recent Developments - The company announced a proposed acquisition of SWK Holdings, which is expected to enhance its healthcare and life sciences exposure [3] - The merger agreement with SWK Holdings includes provisions for share conversions and cash considerations for SWK shareholders [16][17]

Core Insights - Millicom reported strong operational and financial performance in Q3 2025, with significant growth in adjusted EBITDA and net profit [5][6] - The company achieved a record adjusted EBITDA of $695 million, reflecting a margin of 48.9%, and a notable increase in operating profit [4][6] - Millicom's revenue growth was driven by mobile subscriber additions and ARPU expansion, with a year-over-year increase of 3.5% in service revenue [6][8] Financial Highlights - Q3 2025 revenue was $1.42 billion, a slight decrease of 0.7% compared to Q3 2024, but organic growth was 3.0% [4] - Operating profit for Q3 2025 reached $390 million, up 30.1% from the previous year [4] - Net profit attributable to company owners was $195 million, a significant increase from $51 million in Q3 2024 [4] - Adjusted EBITDA for Q3 2025 was $695 million, an 18.7% increase year-over-year [4] - Equity free cash flow for the quarter was $243 million, reflecting a year-to-date increase of $98 million compared to the same period last year [4][6] Strategic Initiatives - The company is focused on executing its strategic plan, which includes advancing inorganic growth initiatives and improving operational efficiency [6] - Millicom aims to achieve an equity free cash flow target of around $750 million for 2025, with a year-end leverage below 2.5x [9] - The company declared an additional interim dividend of $2.5 per share in August, totaling approximately $420 million [8]

Group 1 - Actis, owned by General Atlantic, is interested in reacquiring Sprng Energy from Shell Plc, with a potential buyback deal valued at approximately $1.55 billion enterprise value [1][16] - Sprng Energy currently possesses 2.3 GW of operational renewable energy projects and has an additional 5 GW in the pipeline [1][16] - Other prospective bidders for Sprng Energy include Blackstone and Brookfield Asset Management Inc., indicating strong interest in the renewable energy sector [2][16] Group 2 - The scale of India's green energy market is attracting significant interest from both Indian and global investors, with plans to increase renewable energy capacity to 500 GW by 2030 [4][16] - Inorganic growth is a key strategy in the energy sector, with mergers and acquisitions being a priority for organizations seeking to enhance energy security and scale renewables [7][8] - Recent transactions in the renewable energy space include various acquisitions and IPOs, highlighting the active investment landscape [14][15]

Financial Data and Key Metrics Changes - Organic sales grew by 5% in Q3 2025, with adjusted EBITDA reaching a record $147 million, exceeding initial guidance of $140 million to $145 million [20][30] - Adjusted EBITDA growth would have been 10% when excluding the graphics business divestiture [20] - Adjusted EBITDA margin improved by approximately 20 basis points year over year in constant currency terms, with a margin of 28% when excluding the impact of pass-through metal sales [24][29] Business Line Data and Key Metrics Changes - The electronics segment achieved 7% organic growth, driven by strong performance in semi and assembly, and exceptional volume growth in circuitry solutions [20][23] - Circuitry solutions sales grew 13% organically, supported by demand for data center applications and mobile phone activity [25] - Industrial and specialty organic net sales were flat year over year, but underlying chemistry volumes for the industrial solutions vertical were up mid-single digits [26] Market Data and Key Metrics Changes - The electronics business is projected to exceed $2 billion in revenue following the acquisition of Micromax, which is expected to contribute approximately $40 million of adjusted EBITDA on a full-year basis [17][18] - The offshore business continues to grow, driven by stable energy prices and drilling activity, although a slowdown in drilling activity is anticipated into 2026 [72] Company Strategy and Development Direction - The acquisition of Micromax is seen as a strategic move to enhance the electronics portfolio and is expected to be more than 5% accretive to adjusted EPS [18][19] - The company is focused on disciplined investment in markets it understands and growth businesses that are better under its ownership [18] - Future growth levers include new product introductions in high-value categories and substantial remaining balance sheet capacity for further investments [19] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the future, expecting full-year 2025 adjusted EBITDA to be between $545 million and $550 million, indicating a positive outlook despite market volatility [30] - The company anticipates continued robust demand in leading-edge electronics driven by high-performance computing and data centers [32] - Management noted that while EV volumes are expected to decline, there are substantial customer wins and growth opportunities in power electronics [74] Other Important Information - The company generated $84 million of adjusted free cash flow in Q3 2025, with a net leverage ratio of 1.9 times at the end of the quarter [27][28] - The Micromax transaction is expected to be funded with a combination of cash on hand and modest incremental debt, maintaining financial flexibility for future opportunities [28] Q&A Session Summary Question: Thoughts on Micromax's performance under Element Solutions - Management is excited about Micromax's integration, expecting it to outperform the market due to enhanced connectivity in the supply chain and modest cost synergies [37][38] Question: Update on Kouprion commercialization activities - The mid-scale site for Kouprion is on track to be operational by year-end, with meaningful sales and profits expected next year [40][41] Question: Growth stability of Micromax - Micromax's growth has been stable, with a strong product portfolio that is sticky and specialized for demanding applications [46] Question: Capital flexibility and leverage considerations - The company maintains a long-term target ceiling for leverage at 3.5 times, with plenty of capacity for incremental capital deployment [47] Question: Sustainability of offshore business strength - The offshore business is expected to sustain growth, driven by stable energy prices and ongoing drilling activity [72] Question: Margin performance in industrial solutions - There is potential for further margin expansion in the industrial business as volume growth recovers [68]

Financial Data and Key Metrics Changes - The company reported total assets under management (AUM) of $169 billion as of September 30, which is slightly below the previous quarter level due to net outflows despite favorable market performance [8] - Earnings per share (EPS) increased to $6.69 from $6.25 in the second quarter, reflecting a 7% increase, while year-over-year EPS decreased by 3% due to lower average assets [10][19] - Operating margin improved by 170 basis points to 33%, with an incremental margin above 50% [10][18] Business Line Data and Key Metrics Changes - The ETF business saw significant growth, with AUM reaching $4.7 billion, a 79% increase year-over-year, and the highest quarterly sales and net flows at $0.9 billion each [5][14] - Total sales increased by 12% to $6.3 billion, driven by higher sales in fixed income and alternative strategies [15] - Net outflows for the quarter were $3.9 billion, unchanged from the previous quarter, with institutional net outflows improving from $2.2 billion to $1.5 billion [8][15] Market Data and Key Metrics Changes - Positive net flows were observed in fixed income and alternative strategies, while equity strategies faced headwinds due to a focus on quality-oriented strategies [9][10] - The company noted that flows across products and asset classes in October were trending similarly to the third quarter, with strong ETF sales continuing [9] Company Strategy and Development Direction - The company aims to increase retail separate account offerings, expand ETF availability in key channels, and grow the wealth management business [4][5] - Inorganic growth opportunities remain a focus, with a disciplined approach to adding capabilities or increasing scale [7][28] Management's Comments on Operating Environment and Future Outlook - Management acknowledged the challenging environment for quality-oriented strategies, which have underperformed compared to momentum strategies over the past two years [27][33] - The company remains optimistic about the potential for quality strategies to regain favor, which could enhance performance and flows [27][33] Other Important Information - The company completed a debt refinancing, providing significant liquidity and flexibility to invest in the business and return capital to shareholders [11][20] - The quarterly dividend was increased for the eighth consecutive year, reflecting a commitment to returning capital to shareholders [5][11] Q&A Session Summary Question: What are the key strategies attracting interest in ETFs? - Management indicated that both the ETF wrapper and specific strategies are driving interest, with a focus on expanding access and offerings [24][25] Question: Any updates on inorganic opportunities? - Management confirmed that the environment remains active for potential acquisitions, focusing on high-performing capabilities and private market expansion [26][28] Question: How to improve net flows moving forward? - Management highlighted positive flows in fixed income and alternative strategies, while addressing the need to grow areas less correlated to quality-oriented strategies [32][33] Question: Details on office space consolidation and operating expenses? - Management noted that the benefits of office consolidation are now reflected in the run rate, with expectations for lower operating expenses moving forward [37][38] Question: Status of discrete expenses and buyback activity? - Management stated that discrete expenses related to inorganic activities are ongoing, and buybacks remain a core part of the capital strategy [43][45]

Core Insights - Edelman Financial Engines has appointed Ralph Haberli as acting CEO while considering long-term leadership needs following the resignation of former CEO Jay Shah [2][3] - The firm manages over $308 billion in assets and aims to expand its wealth management services, particularly in defined contribution retirement plans [1][3] Leadership Changes - Former CEO Jay Shah will transition to an advisory role until the end of the year [2] - Ralph Haberli, who joined from Capital Group, will temporarily lead the firm and has full authority during this transition [3] Strategic Direction - Haberli emphasized the firm's unique position to support clients throughout their financial journey, from initial employment to retirement [4] - The company plans to pursue both acquisition and organic growth, leveraging its scale and technology to attract partners [5] Recent Developments - Under Shah's leadership, the firm made significant acquisitions, including two firms with assets totaling $726 million this year [6] - Edelman Financial Engines was formed through the merger of Ric Edelman's RIA and Financial Engines in 2018, with a minority stake acquired by Warburg Pincus in 2021 [5]

Core Insights - Eurobio Scientific reported consolidated results for the first half of fiscal year 2025, showing a revenue increase of 10.4% compared to the same period in 2024, driven by recent acquisitions and a higher share of proprietary products [2][5][7]. Financial Performance - Revenue reached €81.2 million, up from €73.5 million in the first half of 2024, with a comparable growth of €4.5 million (+6.1%) when excluding acquisitions [4][5]. - Adjusted gross margin improved by 14% to €38.2 million, reflecting a gross margin of 47.4%, up from 45.6% in the previous year [4][10]. - EBITDA decreased to €13.2 million from €13.9 million year-over-year, while operating income fell to €10.3 million from €11.2 million [12]. - Net income dropped by 40% to €2.4 million compared to €4 million in the first half of 2024 [13]. Cost Structure - Cost of goods sold increased by 8% to €43 million, while research and development expenses decreased by 27% to €2.1 million [4][11]. - Sales and marketing expenses surged by 52% to €18.1 million, attributed to strengthening sales teams and scope effects from acquisitions [4][11]. - General and administrative expenses remained stable at €7.7 million, including costs related to the transfer of production lines [11]. Cash Flow and Debt - Free cash flow declined to €4.4 million, impacted by changes in working capital and net investment flows [14]. - As of June 30, 2025, the company had cash and cash equivalents of €26.7 million and financial debt of €11.3 million, resulting in net debt of €2.2 million [15]. Strategic Outlook - Eurobio Scientific aims to increase the share of proprietary products to around 50% of its revenue over the next four years, focusing on product development and international expansion [16].

Core Insights - Apollo Global Management (APO) is pursuing growth through an acquisition-driven strategy, focusing on inorganic expansion to enhance its assets under management (AUM) and diversify revenue streams [1][2][24] - The company aims to scale its total AUM to $1.5 trillion by 2029, with significant growth expected in its equity and private lending segments [8][12][13] Inorganic Growth Efforts - Apollo completed the acquisition of Bridge Investment Group Holdings Inc., which adds approximately $50 billion in assets and nearly doubles its real estate AUM to over $110 billion [4][5][11] - The acquisition is expected to enhance Apollo's fee-related earnings and strengthen its offerings for institutional and wealth clients [5][11] Strategic Partnerships - In May 2025, Apollo partnered with JPMorgan Chase and Goldman Sachs to increase liquidity in the private credit market, aiming to originate larger loans more quickly [6] - Strategic alliances with Citigroup and State Street were formed to broaden access to private credit and enhance retail distribution channels [7][10] Revenue Growth and Financial Goals - Apollo has shown strong organic growth, with total GAAP revenues experiencing a three-year CAGR of 63.7% through 2024 [9] - The company expects fee-related earnings to grow at an average annual rate of 20% by 2029, with spread-related earnings projected to grow at 10% [12] Capital Distribution and Shareholder Returns - As of June 30, 2025, Apollo had $2.4 billion in cash and cash equivalents, supporting its capital distribution activities, including a 10.9% increase in its quarterly dividend [14][15] - The company has a share repurchase program authorized for up to $3 billion, with $1.03 billion remaining as of June 30, 2025 [15] Price Performance and Estimates - Over the past year, APO shares have gained 24.1%, outperforming the industry and the S&P 500 Index [16] - The Zacks Consensus Estimate for Apollo's 2025 and 2026 sales indicates year-over-year growth of 18% and 19.4%, respectively [19] Final Thoughts - Apollo's combination of inorganic acquisitions and strong organic growth positions it as a significant player in alternative asset management and private credit [24] - The company's robust liquidity, disciplined capital management, and consistent dividends and share repurchases enhance its attractiveness for long-term investors [25]